Skip to Content
Merck
  • Phosphorylation of PKCδ by FER tips the balance from EGFR degradation to recycling.

Phosphorylation of PKCδ by FER tips the balance from EGFR degradation to recycling.

The Journal of cell biology (2021-01-08)
Ana Lonic, Freya Gehling, Leila Belle, Xiaochun Li, Nicole L Schieber, Elizabeth V Nguyen, Gregory J Goodall, Robert G Parton, Roger J Daly, Yeesim Khew-Goodall
ABSTRACT

Receptor degradation terminates signaling by activated receptor tyrosine kinases. Degradation of EGFR occurs in lysosomes and requires the switching of RAB5 for RAB7 on late endosomes to enable their fusion with the lysosome, but what controls this critical switching is poorly understood. We show that the tyrosine kinase FER alters PKCδ function by phosphorylating it on Y374, and that phospho-Y374-PKCδ prevents RAB5 release from nascent late endosomes, thereby inhibiting EGFR degradation and promoting the recycling of endosomal EGFR to the cell surface. The rapid association of phospho-Y374-PKCδ with EGFR-containing endosomes is diminished by PTPN14, which dephosphorylates phospho-Y374-PKCδ. In triple-negative breast cancer cells, the FER-dependent phosphorylation of PKCδ enhances EGFR signaling and promotes anchorage-independent cell growth. Importantly, increased Y374-PKCδ phosphorylation correlating with arrested late endosome maturation was identified in ∼25% of triple-negative breast cancer patients, suggesting that dysregulation of this pathway may contribute to their pathology.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® esiRNA, targeting human FER
Sigma-Aldrich
O-Phospho-L-tyrosine
Sigma-Aldrich
MISSION® esiRNA, targeting human PTPN14